Rising prevalence of endocrine disorders and increasing health care awareness are major factors that drive the growth of endocrine testing market. However, high cost of development of the technology can hamper the growth of market.
Contrarily, technological advancements such as liquid chromatography-mass spectrometry (LC-MS) is one of the opportunistic factors for the global market.
Increasing prevalence of endocrinal disorders such as diabetes, hypo/hyperthyroidism, infertility, multiple endocrine neoplasia 1 and 2, hypo/hyperadrenocorticism and hypogonadism are expected to fuel growth of endocrine testing market.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/9732
Presence of these disease can be confirmed with measurement of blood hormone level to observe imbalance in their concentration. Globally hypothyroidism and hyperthyroidism are one of fastest growing endocrinal disorder.
According to American Thyroid Association, in 2017, around 20 million U.S. citizens experience thyroid annually. An estimated around 12% of the U.S. population is expected to suffer from thyroid disease in their lifetime.
Moreover, around 60% of people who has thyroid are unaware of their disease. It is common endocrine disorder in emerging economies due to iodine deficiency in diet. According to study published in Indian Journal of Endocrinology and Metabolism (IJEM), thyroid disease in India has incidence of 11% (4-5% for developed countries) and as per epidemiological study published in IJEM in 2011, around 42 million people were affected by the thyroid disorder.
Imbalance in sex hormones such as follicle stimulating hormone lead to various disease including infertility condition. According to report by Maternal Health Task Force, in 2017, around 50 million couples experience infertility globally each year. Other endocrinal disease such as Cushing syndrome and gigantism would also see steady prevalence which would present the growth opportunity in endocrine testing market.
On the other side, high costs of various advanced endocrine tests is one of the prominent factors expected to hamper the endocrine testing market. Despite its increasing uses in diagnosing of various diseases, middle class people are not able to afford it due to price concern.
Apart from this, lack of appropriate healthcare infrastructure and low awareness in developing and underdeveloped regions has also impeded the growth of endocrine testing market. However, increasing efforts from governments to spread healthcare awareness through various programs and projects in developing region may minimize these restraints in the global endocrine testing market in the coming years.
Major players analyzed include Agilent Technologies, Abbott Laboratories, Biomedical Diagnostics, Bio-Rad Laboratories Inc., F.Hoffman-La Roche Ltd, ImmunoDX, Laboratory Corporation, Nano EnTek, Siemens AG, and Thermo Fisher Scientific Inc.,
For Report Customization: https://www.alliedmarketresearch.com/request-for-customization/9732
Key benefits of the report:
- This study presents the analytical depiction of the global endocrine testing system industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global endocrine testing system market share.
- The current market is quantitatively analyzed from 2020 to 2027 to highlight the global endocrine testing system market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global endocrine testing system market analysis based on competitive intensity and how the competition will take shape in coming years.
Thanks for reading this article; you can also get an individual chapter-wise section or region-wise report versions like North America, Europe, or Asia.
If you have any special requirements, please let us know and we will offer you the report as per your requirements.
Lastly, this report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
AMR launched its user-based online library of reports and company profiles, Avenue. An e-access library is accessible from any device, anywhere, and at any time for entrepreneurs, stakeholders, researchers, and students at universities. With reports on more than 60,000 niche markets with data comprising of 600,000 pages along with company profiles on more than 12,000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients’ requirements is complemented with analyst support and customization requests.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll-Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter